DrugJul 15, 2026
QuVa Pharma Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL recall — FDA D-0664-2026
Failed Impurities/Degradation Specifications
Class IIFDA: OngoingQuVa Pharma, Inc.
Recall history in this database
Classification mix: Class II: 32, Class III: 2, Class I: 2.
DrugNov 5, 2025
QuVa Pharma R.E.C.K recall — FDA D-0113-2026
Presence of Particulate Matter
Class IIFDA: OngoingQuVa Pharma, Inc.
DrugApr 2, 2025
QuVa Pharma fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 recall — FDA D-0296-2025
Lack of Assurance of Sterility
Class IIFDA: OngoingQuVa Pharma, Inc.
DrugApr 2, 2025
QuVa Pharma fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 recall — FDA D-0295-2025
Lack of Assurance of Sterility
Class IIFDA: OngoingQuVa Pharma, Inc.
DrugApr 2, 2025
QuVa Pharma fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 recall — FDA D-0297-2025
Lack of Assurance of Sterility
Class IIFDA: OngoingQuVa Pharma, Inc.
DrugOct 5, 2022
QuVa Pharma oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride recall — FDA D-1544-2022
Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).
Class IIIFDA: TerminatedQuVa Pharma, Inc.
DrugJun 17, 2020
QuVa Pharma oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection recall — FDA D-1302-2020
Subpotent drug - Product did not contain drug.
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 2000 mcg/100 mL (20 mcg/mL) in 0.9% Sodium Chloride, 100 mL Bag recall — FDA D-0563-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 2750 mcg/55 mL (50 mcg/mL) 55 mL Syringe, Preservative Free, Rx, QuVA recall — FDA D-0558-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 2500 mcg/50 mL (50 mcg/mL) 50 mL bag, Preservative Free, Rx, QuVA recall — FDA D-0569-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) recall — FDA D-0548-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag recall — FDA D-0567-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) recall — FDA D-0561-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 800 mcg/200 mL (4 mcg/mL) BUPivacaine HCl 0.1667% 333.4 mg/200 mL recall — FDA D-0568-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride 55 mL Syringe recall — FDA D-0572-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.1% 200 mg/200 mL (1 mg/mL) recall — FDA D-0564-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg/100 mL (1 mg/mL) recall — FDA D-0565-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 400 mcg/200 mL (2 mcg/mL) 0.1% ROPivacaine HCl 200 mg/200 mL (1 mg/mL) recall — FDA D-0562-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 500 mcg/250 mL (2 mcg/mL) 0.125% BUPivacaine HCl 312.5 mg/250 mL recall — FDA D-0547-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 1000 mcg/100 mL (10 mcg/mL) in 0.9% Sodium Chloride Preservative Free recall — FDA D-0555-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.125% 125 mg/100 mL recall — FDA D-0550-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 1000 mcg/20 mL (50 mcg/mL) 20 mL in 20 mL Syringe Preservative Free recall — FDA D-0566-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 250 mcg/5 mL (50 mcg/mL), 5 mL Syringe, Preservative Free, Rx, QuVA recall — FDA D-0560-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
DrugDec 11, 2019
QuVa Pharma fentaNYL 2500 mcg/250 mL (10 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag recall — FDA D-0553-2020
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Class IIFDA: TerminatedQuVa Pharma, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies QuVa Pharma, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.